Search Results - Tariq I. Mughal

Refine Results
  1. 1
    Principal long-term adverse effects of imatinib in patients with chronic myeloid leukemia in chronic phase

    Principal long-term adverse effects of imatinib in patients with chronic myeloid leukemia in chronic phase by Tariq I. Mughal

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Biology and Clinical Management of Myeloproliferative Neoplasms and Development of the JAK Inhibitor Ruxolitinib

    Biology and Clinical Management of Myeloproliferative Neoplasms and Development of the JAK Inhibitor Ruxolitinib by John Mascarenhas, Tariq I. Mughal, Srđan Verstovšek

    Published 2012
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Myelofibrosis-associated complications: pathogenesis, clinical manifestations, and effects on outcomes

    Myelofibrosis-associated complications: pathogenesis, clinical manifestations, and effects on outcomes by Srđan Verstovšek, Tariq I. Mughal, Kris Vaddi, Nicholas Sarlis

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Next-generation sequencing of idiopathic multicentric and unicentric Castleman disease and follicular dendritic cell sarcomas

    Next-generation sequencing of idiopathic multicentric and unicentric Castleman disease and follicular dendritic cell sarcomas by Alexandra Nagy, Aparna Bhaduri, Nahid Shahmarvand, Jahanbanoo Shahryari, James L. Zehnder, Roger A. Warnke, Tariq I. Mughal, Siraj Ali, Robert S. Ohgami

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Loss of heterozygosity as a marker of homologous repair deficiency in multiple myeloma: a role for PARP inhibition?

    Loss of heterozygosity as a marker of homologous repair deficiency in multiple myeloma: a role for PARP inhibition? by Charlotte Pawlyn, Andrea Loehr, Cody Ashby, Ruslana G. Tytarenko, Shayu Deshpande, James Sun, Kyle Fedorchak, Tariq I. Mughal, Faith E. Davies, Brian A. Walker, Gareth J. Morgan

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Efficacy and manageable safety of tagraxofusp in blastic plasmacytoid dendritic cell neoplasm: a case series of pediatric and adolescent/young adult patients

    Efficacy and manageable safety of tagraxofusp in blastic plasmacytoid dendritic cell neoplasm: a case series of pediatric and adolescent/young adult patients by Naveen Pemmaraju, Branko Cuglievan, Joseph A. Lasky, Albert Kheradpour, Nobuko Hijiya, Anthony S. Stein, Soheil Meshinchi, Craig A. Mullen, Emanuele Angelucci, Luciana Vinti, Tariq I. Mughal, Anna Pawłowska

    Published 2024
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Chronic myeloid leukemia: reminiscences and dreams

    Chronic myeloid leukemia: reminiscences and dreams by Tariq I. Mughal, Jerald P. Radich, Michael W. Deininger, Jane F. Apperley, Timothy P. Hughes, Christine J. Harrison, Carlo Gambacorti‐Passerini, Giuseppe Saglio, Jorge E. Cortés, George Q. Daley

    Published 2016
    Get full text
    Revisão
    Save to List
    Saved in:
  8. 8
    Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm

    Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm by Naveen Pemmaraju, Kendra Sweet, Anthony S. Stein, Eunice S. Wang, David A. Rizzieri, Sumithira Vasu, Todd Rosenblat, Christopher Brooks, Nassir Habboubi, Tariq I. Mughal, Hagop M. Kantarjian, Marina Konopleva, Andrew A. Lane

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical Trials

    Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical Trials by Natalie Galanina, Rafael Bejar, Michael Y. Choi, Aaron M. Goodman, Matthew J. Wieduwilt, Carolyn Mulroney, Lisa Kim, Huwate Yeerna, Pablo Tamayo, Jo‐Anne Vergilio, Tariq I. Mughal, Vincent A. Miller, Catriona Jamieson, Razelle Kurzrock

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both

    Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both by Steffen Koschmieder, Tariq I. Mughal, Hans Carl Hasselbalch, Giovanni Barosi, Peter Valent, Jean‐Jacques Kiladjian, Georg Jeryczynski, Heinz Gisslinger, Jonas S. Jutzi, Heike L. Pahl, Rüdiger Hehlmann, Alessandro M. Vannucchi, Francisco Cervantes, Richard T. Silver, Tiziano Barbui

    Published 2016
    Get full text
    Revisão
    Save to List
    Saved in:
  11. 11
    An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms

    An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative ne... by Tariq I. Mughal, Nicholas C.P. Cross, E. Padron, Ramón V. Tiu, Michael R. Savona, Luca Malcovati, Raoul Tibes, Rami S. Komrokji, Jean‐Jacques Kiladjian, G. Garcia-Manero, Attilio Orazi, Ruben A. Mesa, Jaroslaw P. Maciejewski, P. Fenaux, Raphaël Itzykson, G J Mufti, Éric Solary, Alan F. List

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Chronic Myelogenous Leukemia

    Chronic Myelogenous Leukemia by Susan O’Brien, Ellin Berman, Hossein Borghaei, Daniel J. DeAngelo, Marcel P. Devetten, Steven M. Devine, Harry P. Erba, Jason Gotlib, Madan Jagasia, Joseph O. Moore, Tariq I. Mughal, Javier Pinilla‐Ibarz, Jerald P. Radich, Neil P. Shah, Paul J. Shami, Benjamin D. Smith, David S. Snyder, Martin S. Tallman, Moshe Talpaz, Meir Wetzler

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults

    An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults by Michael R. Savona, Luca Malcovati, Rami S. Komrokji, Ramón V. Tiu, Tariq I. Mughal, Attilio Orazi, Jean‐Jacques Kiladjian, Eric Padron, Éric Solary, Raoul Tibes, Raphaël Itzykson, Mario Cazzola, Ruben A. Mesa, Jaroslaw P. Maciejewski, Pierre Fenaux, Guillermo Garcia‐Manero, Aaron T. Gerds, Guillermo Sanz, Charlotte M. Niemeyer, Francisco Cervantes, Ulrich Germing, Nicholas C.P. Cross, Alan F. List

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Phase 1b trial of tagraxofusp in combination with azacitidine with or without venetoclax in acute myeloid leukemia

    Phase 1b trial of tagraxofusp in combination with azacitidine with or without venetoclax in acute myeloid leukemia by Andrew A. Lane, Jacqueline S. Garcia, Evangeline G. Raulston, Jada L. Garzon, Ilene Galinsky, Emilie W. Baxter, Rebecca Leonard, Daniel J. DeAngelo, Marlise R. Luskin, Christopher R. Reilly, Maximilian Stahl, Richard M. Stone, Rahul S. Vedula, Martha Wadleigh, Eric S. Winer, Tariq I. Mughal, Christopher Brooks, Ira Gupta, Kristen E. Stevenson, Donna Neuberg, Siyang Ren, Julia Keating, Marina Konopleva, Anthony S. Stein, Naveen Pemmaraju

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker

    Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker by Shweta S. Chavan, Jie He, Ruslana G. Tytarenko, S Deshpande, Pragi Patel, Mark Bailey, Joshua Epstein, Owen Stephens, Niels Weinhold, Nathan Petty, Doug Steward, Leo Rasche, Michael Bauer, Cody Ashby, Erich A. Peterson, Siraj M. Ali, Jeffrey S. Ross, V.A. Miller, P. J. Stephens, Sharmilan Thanendrarajan, Carolina Schinke, Maurizio Zangari, Frits van Rhee, Bart Barlogie, Tariq I. Mughal, Faith E. Davies, Gareth J. Morgan, Brian A. Walker

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Hybrid capture-based genomic profiling of circulating tumor DNA from patients with estrogen receptor-positive metastatic breast cancer

    Hybrid capture-based genomic profiling of circulating tumor DNA from patients with estrogen receptor-positive metastatic breast cancer by Jon Chung, Dean C. Pavlick, Ryan J. Hartmaier, Alexa B. Schrock, Lauren Young, Brady Forcier, Pengju Ye, Maren K. Levin, Michael E. Goldberg, Howard A. Burris, Laurie M. Gay, Anthony Hoffman, Philip J. Stephens, Garrett M. Frampton, Doron Lipson, David Nguyen, Shridar Ganesan, B. H. Park, Linda T. Vahdat, Brian Leyland‐Jones, Tariq I. Mughal, Lajos Pusztai, Joyce O’Shaughnessy, V.A. Miller, Jeffrey S. Ross, Siraj M. Ali

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Oncogenic TRK fusions are amenable to inhibition in hematologic malignancies

    Oncogenic TRK fusions are amenable to inhibition in hematologic malignancies by Justin Taylor, Dean C. Pavlick, Akihide Yoshimi, Christina Marcelus, Stephen S. Chung, Jaclyn F. Hechtman, Ryma Benayed, Emiliano Cocco, Benjamin H. Durham, Lillian Bitner, Daichi Inoue, Young Rock Chung, Kerry Mullaney, Justin M. Watts, Eli L. Diamond, Lee A. Albacker, Tariq I. Mughal, Kevin Ebata, Brian B. Tuch, Nora Ku, Maurizio Scaltriti, Mikhail Roshal, Maria E. Arcila, Siraj M. Ali, David M. Hyman, Jae H. Park, Omar Abdel‐Wahab

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Clonal diversity predicts adverse outcome in chronic lymphocytic leukemia

    Clonal diversity predicts adverse outcome in chronic lymphocytic leukemia by Alexander C. Leeksma, Justin Taylor, Bian Wu, Jeffrey R. Gardner, Jie He, Michelle Nahas, Mithat Gönen, Wendimagegn Alemayehu, Doreen te Raa, Tatjana Walther, Jennifer Hüllein, Sascha Dietrich, Rainer Claus, Fransien de Boer, Koen de Heer, Julie Dubois, Maria Dampmann, Jan Dürig, Marinus H. J. van Oers, Christian H. Geisler, Eric Eldering, Ross L. Levine, Vincent A. Miller, Tariq I. Mughal, Nicole Lamanna, Mark G. Frattini, Mark Heaney, Andrew D. Zelenetz, Thorsten Zenz, Omar Abdel‐Wahab, Arnon P. Kater

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Non-Hodgkin’s Lymphomas

    Non-Hodgkin’s Lymphomas by Andrew D. Zelenetz, Jeremy S. Abramson, Ranjana H. Advani, Charalambos Andreadis, John C. Byrd, Myron S. Czuczman, Luis Fayad, Andres Forero, Martha Glenn, Jon P. Gockerman, Leo I. Gordon, Nancy L. Harris, Richard T. Hoppe, Steven M. Horwitz, Mark Kaminski, Youn H. Kim, Ann S. LaCasce, Tariq I. Mughal, Auyporn Nademanee, Pierluigi Porcu, Oliver W. Press, Leonard R. Prosnitz, Nashitha Reddy, Mitchell R. Smith, Lubomir Sokol, Lode J. Swinnen, Julie M. Vose, William G. Wierda, Joachim Yahalom, Furhan Yunus

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Non-Hodgkin's Lymphomas

    Non-Hodgkin's Lymphomas by Andrew D. Zelenetz, Jeremy S. Abramson, Ranjana H. Advani, Charalambos Andreadis, John C. Byrd, Myron S. Czuczman, Luis Fayad, Andres Forero, Martha Glenn, Jon P. Gockerman, Leo I. Gordon, Nancy L. Harris, Richard T. Hoppe, Steven M. Horwitz, Mark Kaminski, Youn H. Kim, Ann S. LaCasce, Tariq I. Mughal, Auyporn Nademanee, Pierluigi Porcu, Oliver W. Press, Leonard R. Prosnitz, Nashitha Reddy, Mitchell R. Smith, Lubomir Sokol, Lode J. Swinnen, Julie M. Vose, William G. Wierda, Joachim Yahalom, Furhan Yunus

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: